NEW YORK, Aug. 12 (GenomeWeb News) - CombiMatrix and the Biodesign Institute at Arizona State University plan to co-develop a peptide array synthesizer using CombiMatrix's virtual-flask technology, the partners said today.
Terms of the agreement call for the partners to develop a peptide synthesizer that can build polypeptide arrays on CombiMatrix CustomArrays platform. As part of the alliance, the Biodesign Institute's Center for BioOptical Nanotechnology will buy CombiMatrix equipment and pay for the development costs. CombiMatrix, for its part, will grant technology rights and contributing expertise.
CombiMatrix and the Institute will share revenue from any peptide array synthesizer, peptide array products, or intellectual property that might be developed.
The Arizona Technology Enterprises, the technology commercialization company for ASU and the Biodesign Institute, helped facilitate the deal. The Center for BioOptical Nanotechnology "will pursue rapid commercialization of these technologies," CombiMatrix said in a statement.